Search results
23 hours ago · Precision in Diagnosing Coronary Artery Disease: When Precise Testing Leads to Better Results. Do you know when to chose anatomical or functional testing in assessing your patients with suspected coronary artery disease (CAD)? Authors: Robert A. Harrington, MD; Leslee J. Shaw, PhD; Martha Gulati, MD; Gregg W. Stone, MD; Sreekanth Vemulapalli, MD.
3 days ago · Tuesday, December 3, 2024 13:00 to 16:15. Montreal Neurological Institute de Grandpre Communications Centre, 3801 rue University, Montreal, QC, H3A 2B4, CA. Add to calendar. This workshop will serve to discuss the indications and, prescription, and management of adverse events associated with anti-amyloid therapy with monoclonal anti-bodies.
Being a board member of the Dublin Neurological Institute affords Suzanne the opportunity to contribute to the success of this progressive and innovative model of healthcare design and delivery.
Apr 19, 2019 · The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service. If you need immediate support or to place an order, please call or email customer service: 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F) 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
Oct 23, 2024 · Funding: The CARDIA study is conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the University of Alabama at Birmingham (75N92023D00002 & 75N92023D00005), Northwestern University (75N92023D00004), University of Minnesota (75N92023D00006) and Kaiser Foundation Research Institute (75N92023D00003). Also supported in part by (NIA) R35AG071916 and (NIA ...
The UCL Queen Square Institute of Neurology is a global leader in neuroscience. Part of the Faculty of Brain Sciences, we are at the forefront of the mission to translate neuroscience discovery into diagnostics and treatments for patients with neurological diseases.
Oct 23, 2024 · Study design. The Extended LAST STRONG (LAMA2-MD and SELENON-RM To Study Trial Readiness, Outcome measures and Natural history) is a single-center, prospective, observational study with repeated measurements performed at the Department of Neurology and Pediatric Neurology using the infrastructure of the neuromuscular center of expertise at Radboud university medical center, The Netherlands.